Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements of Comprehensive Loss

v3.22.1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue from Contract with Customer [Abstract]    
Product Revenue
Product Cost of Sales
Gross Income
Administrative Expenses 6,420,092 2,946,703
Research and Development Expenses 6,745,104 2,466,924
Accretion of Debt Discount 608,460 1,191,859
Amortization of Intangible Assets 18,334
Stock Based Compensation 855,000
Stock Option Modification Expenses 15,036,051 2,009,145
Loss from Operations (28,809,707) (9,487,965)
Other (Income) Expenses    
Interest and Dividend Income (8,907) (141)
Gain on Sales of Marketable Securities (39,597)
Unrealized Loss on Marketable Securities 42,793
Gain on Debt Forgiveness (180,257)
Uninsured Casualty Losses 1,265,306
Total Other Income 1,079,338 (141)
Loss Before Income Tax (29,889,045) (9,487,824)
Income Tax Benefit
Net Loss $ (29,889,045) $ (9,487,824)
Basic and Dilutive net loss per common share $ (0.85) $ (0.34)
Weighted average basic and diluted common shares outstanding 35,017,244 28,188,438